Intracoronary adenosine compared with adrenaline and verapamil in the treatment of no-reflow phenomenon following primary PCI in STEMI patients
Authors:
- 4 June 2024
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 410, 132228
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Predictors of no- reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, TrivandrumIndian Heart Journal, 2017
- Management of No-Reflow Phenomenon in the Catheterization LaboratoryJACC: Cardiovascular Interventions, 2017
- Intracoronary AdenosineJACC: Cardiovascular Interventions, 2015
- REstoration of COronary flow in patients with no-reflow after primary coronary interVEntion of acute myocaRdial infarction (RECOVER)American Heart Journal, 2012
- Management of the no-reflow phenomenonPharmacology & Therapeutics, 2011
- Local Delivery Versus Intracoronary Infusion of Abciximab in Patients With Acute Coronary SyndromesJACC: Cardiovascular Interventions, 2010
- Myocardial No-Reflow in HumansJACC, 2009
- High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo‐controlled pilot studyCatheterization and Cardiovascular Interventions, 2007
- Intracoronary verapamil for reversal of no‐reflow during coronary angioplasty for acute myocardial infarctionCatheterization and Cardiovascular Interventions, 2002
- Resolution of refractory no‐reflow with intracoronary epinephrineCatheterization and Cardiovascular Interventions, 2002